NACA

Nascent polypeptide-associated complex subunit alpha · Q13765 · NACA on Sugi Atlas →

0 patent compounds predicted against NACA, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NACA by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Dental Fluorosis Risk by the Use of Acidulated Fluoride Dentifrice PHASE4COMPLETED
A Pilot Study - Safety and Efficacy of Nailprotex® for Onychomycosis Treatment PHASE4COMPLETED
Use of Essential Oils as Natural Therapies PHASE3COMPLETED
Antifungal Drugs in Treatment of Onychomycosis PHASE3UNKNOWN
Study Comparing SUBA™-Itraconazole With SPORANOX® (Itraconazole) in the Treatment of Onychomycosis PHASE2COMPLETED
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail PHASE2COMPLETED
Topical Cyclosporine Suspension for the Treatment of Brittle Nails PHASE2COMPLETED
Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy PHASE2COMPLETED
Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis PHASE1UNKNOWN
Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' Nails nanCOMPLETED
Subclinical Nail Involvement in Relevant Skin Diseases nanUNKNOWN
Analysis and Measurement of Nail Morphology nanACTIVE_NOT_RECRUITING
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Exome Evaluation in Patients Living With Diabetes Complicated by Charcot Neuroarthropathy. nanCOMPLETED
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population nanCOMPLETED
Prevalence and Clinical Characteristics of the Fungal Nail and Feet Infection in Patients With Hallux Valgus nanCOMPLETED
Neurological and Psychological Assessment of Neurocutaneous Syndromes in Upper Egypt Children nanUNKNOWN
Prevalence of Onychodystrophy in Patients With Chronic Venous Disease of the Lower Limbs nanCOMPLETED
Etude rétrospective Monocentrique MATRIX nanCOMPLETED
Risk Factors for Foot Ulceration in the Chronic Kidney Disease (CKD) Population nanUNKNOWN
miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi nanCOMPLETED
Defining Treatment Outcomes and Genetic Architecture in Idiopathic Toe Walking* nanCOMPLETED
Impact of Dysregulation of Core Body Temperature on Sleep in Patients With Hypohidrotic Ectodermal Dysplasia nanCOMPLETED
A Randomized Study to Evaluate the Efficacy of Herbal Ingredients Combined With a Carrier System (Phytonail) Compared With Amorolfine 5% Nail Lacquer (Loceryl) in the Treatment of Toenail Onychomycosis nanUNKNOWN
Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis nanUNKNOWN
Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease. nanUNKNOWN
Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment nanUNKNOWN
RBG: Regular, Bare, Gel: Does Type of Nail Polish Affect Bacterial Counts After Surgical Scrubbing? nanCOMPLETED
NGS for HLA Typing of Donors and récipients oh Hematopoietic Stem Cells nanCOMPLETED
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a NACA binder may also engage these)

ProteinNameSimilarity
Q6QN10 1.000 Q6QN10 →
Q5E9A1 1.000 Q5E9A1 →
Q6IP73 1.000 Q6IP73 →
Q68F90 1.000 Q68F90 →
Q60817 1.000 Q60817 →
Q5R9I9 1.000 Q5R9I9 →
Q8AWF2 1.000 Q8AWF2 →
Q8JIU7 1.000 Q8JIU7 →
Q9H009 1.000 Q9H009 →
Q7SI17 0.997 Q7SI17 →
P0C2C7 0.996 P0C2C7 →
Q4I2J8 0.995 Q4I2J8 →
A4RC89 0.995 A4RC89 →
Q94JX9 0.995 Q94JX9 →
A7EIZ1 0.994 A7EIZ1 →
A6R641 0.994 A6R641 →
Q6ICZ8 0.994 Q6ICZ8 →
Q9M612 0.993 Q9M612 →
Q1DHR3 0.993 Q1DHR3 →
Q2H4Z2 0.993 Q2H4Z2 →
Q86S66 0.993 Q86S66 →
Q61UX1 0.993 Q61UX1 →
Q94518 0.993 Q94518 →
Q9SZY1 0.992 Q9SZY1 →
A6SB28 0.991 A6SB28 →
A1DLM0 0.990 A1DLM0 →
Q9BZK3 0.990 Q9BZK3 →
A2R4V1 0.990 A2R4V1 →
Q2U955 0.990 Q2U955 →
A1CMF8 0.989 A1CMF8 →